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Background
House Dust Mites are important etiological agents of
respiratory allergy. Allergen mixtures are often used for
specific immunotherapy in polysensitized patients,
although scientific evidence to support its efficacy, safety
and stability is scarce. Sublingual immunotherapy (SLIT)
is being gradually accepted as an alternative to conven-
tional subcutaneous immunotherapy. For SLIT, higher
allergen doses are recommended, so the development of
pharmaceutical formulations allowing the administration
of such high doses is particularly relevant. Therefore,
the aim of this work was to develop and evaluate liquid
formulations of allergenic extracts of house dust mites:
Dermatophagoides pteronyssinus, Dermatophagoides
siboney and Blomiatropicalis, containing glycerol, for
administration as sublingual vaccine.
Methods
Starting from the freeze-dried active ingredients of stan-
dardized allergen products, developed by National Cen-
ter of Bioproducts (BIOCEN, Cuba), there were
obtained several formulation variants of the mixture of
three allergens, with glycerol concentrations ranging
from 20 to 50%. Biologic activity was measured by IgE
inhibition ELISA and in-vivo Prick Test.
Results
The mixture of three allergens, as well as, individual for-
mulations at two concentration levels: 20 000 or 200 000
BU/mL, containing glycerol 20 or 50% showed stability at
room temperature for 6 months in a similar extent, in
contrast to aqueous formulation that at the highest con-
centration showed a fast degradation. Glycerol 20 or 50%
was also effective as microbiological preservative agent.
Conclusions
The technical feasibility and compatibility of ingredients
of these formulations was experimentally demonstrated.
The formulation containing 200 000 BU/mL, 10 times
the concentration used for SCIT would be particularly
suitable for SLIT.
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